Kumar Sankaran is the Chief Executive Office of Leucine Rich Bio Private Limited and the Designated Partner in Gene Express LLP.
He is a business leader with a professional experience of 15+ years in Healthcare Research and Delivery. In his current role he is spearheading the growth and innovation in the Microbiome domain for the Asian market. He is passionate about driving the paradigm shift from "sick care" to "health care".
Friday 13th october
The Future of Healthcare Through Innovations
- Role of Genomics in Biotech
- Personalized Health
- Prevention as an Approach to Wellbeing
- Patient-centric Healthcare
Giridhar K. Chenji, Head- Program Management, Manufacturing and Technology, Immuneel Therapeutics
Kumar Sankaran, CEO, Luciene Rich Bio Ltd
Session Moderated by:
Manbeena Chawla PH.D, Executive Editor, Biospectrum Magazine India